Diseases & Disorders
(G81)
IRS Verified
DX Registered
990 on File
SOUTH JERSEY AGAINST AIDS INC DBA SOUTH JERSEY AIDS ALLIANCE
Financial strength (30%)
63/100
Reliability (20%)
55/100
Effectiveness (25%)
73/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$4.7M
Total Revenue
$4.8M
Total Expenses
$1.0M
Net Assets
42
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
98.3%
Fundraising Efficiency
0.0%
Operating Reserve
2.55x
Liability-to-Asset
61.8%
Revenue Diversification
98.7%
Executive Compensation
$259K
Compared with Peers
FY 2024
Compared with 638 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
98.3% | 82.3% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
1.7% | 11.5% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 2.8% |
P10P90
|
Top quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
0.0% | 110.9% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
2.6 mo | 11.4 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
61.8% | 12.7% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
98.7% | 91.5% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
11.1% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
17.5% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-2.2% | 2.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $4.7M | $4.8M | $1.0M | 98.3% | 42 |
| 2023 | $4.2M | $4.0M | $1.1M | 98.8% | 48 |
| 2022 | $3.2M | $3.0M | $969K | 99.1% | 49 |
| 2021 | $3.8M | $3.8M | N/A | — | 41 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.